Evaluation of the Prevalence of Anti-infective Drug Compliance in Pediatric Patients Hospitalized at Nimes University Hospital After Return Home (PEDIAOBST)

Nowadays, resistance to anti-infectives has become a global public health problem and its increased prevalence threatens human health.

To date, few studies have focused on drug compliance in the paediatric population and it varies according to the pathology This drug adherence in the paediatric population is directly linked to outpatient care by the parents or the child's immediate family. In addition, there are no studies on adherence to antibiotics prescribed at the end of hospitalization in the paediatric population.

In this context, it seems urgent to seek an intervention capable of leading to responsible and appropriate use of antibiotics in order to improve efficiency in the drug management of acute paediatric infections.

This pilot study would characterize pediatric patients and determine the compliance rate in this population.

Study Overview

• Status: Completed
• Conditions: Pediatric Population; Anti Infective

• Study Type: Observational
• Enrollment (Actual): 75

Contacts and Locations

Study Locations

• France
  • Nîmes, France, 30029
    • Chu Nimes

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: No older than 16 years (Child)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

The patients included in the study are patients under 16 years of age (< 16 years of age) admitted to full hospitalization in the paediatric units

Description

Inclusion Criteria:

• The patient is under 16 years of age (< 16 years of age).
• The patient is admitted to a full hospitalization in one of the 2 paediatric units of the University Hospital of Nîmes.
• The patient is discharged with a prescription for anti-infectives to be taken at home, for a maximum of 30 days.
• The patient and the holder of parental authority are available for a follow-up of 1 month after discharge from hospital.

Exclusion Criteria:

-

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Rate of patients observing anti-infectives	2018

Secondary Outcome Measures

Outcome Measure	Time Frame
Rehospitalization rates / emergency visits related to worsening infection	2018

Other Outcome Measures

Outcome Measure	Time Frame
Rate of observing patients who have recovered their anti-infective treatment	2018
Rate of observing patients who have taken anti-infective treatment as prescribed	2018
Sociodemographic and clinical characteristics	2018
Overall success rate in the quiz on understanding anti-infectives	2018

Collaborators and Investigators

• Sponsor: Centre Hospitalier Universitaire de Nīmes

Study record dates

Study Major Dates

• Study Start (Actual): March 6, 2018
• Primary Completion (Actual): May 4, 2018
• Study Completion (Actual): June 10, 2018

Study Registration Dates

• First Submitted: July 1, 2019
• First Submitted That Met QC Criteria: July 3, 2019
• First Posted (Actual): July 5, 2019

Study Record Updates

• Last Update Posted (Actual): August 7, 2019
• Last Update Submitted That Met QC Criteria: August 5, 2019
• Last Verified: June 1, 2019

More Information

Terms related to this study

• Other Study ID Numbers: Mobilité/2017/GLB

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No